Novocure Current Deferred Revenue vs Long Term Debt Analysis

NVCR Stock

USD 22.48 0.77 3.55%

Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Current Deferred Revenue and its Long Term Debt accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Current Deferred Revenue vs Long Term Debt

Current Deferred Revenue vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Current Deferred Revenue account and Long Term Debt. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Novocure's Current Deferred Revenue and Long Term Debt is 0.93. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Current Deferred Revenue and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Novocure are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Current Deferred Revenue i.e., Novocure's Current Deferred Revenue and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Long Term Debt

Long-term debt is a debt that Novocure has held for over one year. Long-term debt appears on Novocure balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Novocure balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.At this time, Novocure's Selling General Administrative is relatively stable compared to the past year. As of 02/17/2025, Sales General And Administrative To Revenue is likely to grow to 0.67, while Tax Provision is likely to drop slightly above 9.1 M.

	2022	2023	2024	2025 (projected)
Interest Expense	3.3M	3.3M	3.8M	7.6M
Depreciation And Amortization	10.6M	11.0M	12.6M	7.8M

Interest Expense Depreciation And Amortization

Novocure fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.98	0.46	0.97	0.87	0.59	0.88	0.93	0.96	-0.86	0.98	0.57	0.95	0.99	0.99	0.99	1.0	0.84	0.74	0.99	0.99	0.78	0.48	0.9	0.99	0.84
Short Long Term Debt Total	0.98		0.45	0.97	0.81	0.57	0.82	0.93	0.99	-0.9	0.97	0.48	0.94	0.98	0.98	0.99	0.97	0.85	0.78	0.98	0.99	0.83	0.4	0.9	0.99	0.85
Other Current Liab	0.46	0.45		0.56	0.18	0.27	0.28	0.65	0.4	-0.57	0.55	0.4	0.64	0.55	0.45	0.48	0.44	0.14	0.38	0.38	0.49	0.52	0.43	0.45	0.5	0.78
Total Current Liabilities	0.97	0.97	0.56		0.76	0.56	0.79	0.98	0.96	-0.93	0.99	0.53	0.98	0.99	0.97	0.98	0.96	0.82	0.76	0.95	0.99	0.82	0.38	0.9	0.99	0.92
Total Stockholder Equity	0.87	0.81	0.18	0.76		0.56	0.98	0.69	0.79	-0.62	0.77	0.64	0.71	0.81	0.86	0.82	0.88	0.82	0.59	0.88	0.82	0.65	0.6	0.83	0.81	0.56
Other Liab	0.59	0.57	0.27	0.56	0.56		0.52	0.43	0.56	-0.67	0.5	0.37	0.45	0.59	0.65	0.58	0.56	0.78	0.62	0.56	0.58	0.68	0.64	0.66	0.58	0.35
Net Tangible Assets	0.88	0.82	0.28	0.79	0.98	0.52		0.74	0.8	-0.66	0.8	0.7	0.76	0.83	0.86	0.84	0.89	0.8	0.63	0.88	0.84	0.71	0.57	0.88	0.83	0.63
Property Plant And Equipment Net	0.93	0.93	0.65	0.98	0.69	0.43	0.74		0.91	-0.89	0.99	0.53	1.0	0.96	0.92	0.95	0.92	0.7	0.69	0.9	0.95	0.79	0.31	0.85	0.96	0.97
Net Debt	0.96	0.99	0.4	0.96	0.79	0.56	0.8	0.91		-0.9	0.95	0.38	0.92	0.95	0.96	0.98	0.96	0.85	0.75	0.98	0.98	0.82	0.39	0.9	0.98	0.82
Retained Earnings	-0.86	-0.9	-0.57	-0.93	-0.62	-0.67	-0.66	-0.89	-0.9		-0.89	-0.36	-0.9	-0.89	-0.88	-0.89	-0.84	-0.82	-0.74	-0.85	-0.9	-0.93	-0.36	-0.91	-0.9	-0.86
Accounts Payable	0.98	0.97	0.55	0.99	0.77	0.5	0.8	0.99	0.95	-0.89		0.54	0.99	0.99	0.96	0.98	0.97	0.78	0.72	0.95	0.98	0.79	0.35	0.88	0.99	0.93
Cash	0.57	0.48	0.4	0.53	0.64	0.37	0.7	0.53	0.38	-0.36	0.54		0.54	0.59	0.57	0.53	0.57	0.46	0.52	0.47	0.54	0.41	0.43	0.56	0.54	0.49
Non Current Assets Total	0.95	0.94	0.64	0.98	0.71	0.45	0.76	1.0	0.92	-0.9	0.99	0.54		0.97	0.93	0.96	0.94	0.72	0.71	0.92	0.96	0.79	0.33	0.86	0.97	0.96
Non Currrent Assets Other	0.99	0.98	0.55	0.99	0.81	0.59	0.83	0.96	0.95	-0.89	0.99	0.59	0.97		0.99	0.99	0.98	0.82	0.77	0.96	0.99	0.8	0.46	0.9	0.99	0.89
Other Assets	0.99	0.98	0.45	0.97	0.86	0.65	0.86	0.92	0.96	-0.88	0.96	0.57	0.93	0.99		0.99	0.99	0.88	0.78	0.98	0.99	0.8	0.49	0.9	0.99	0.82
Long Term Debt	0.99	0.99	0.48	0.98	0.82	0.58	0.84	0.95	0.98	-0.89	0.98	0.53	0.96	0.99	0.99		0.99	0.84	0.77	0.98	1.0	0.8	0.43	0.9	1.0	0.86
Cash And Short Term Investments	1.0	0.97	0.44	0.96	0.88	0.56	0.89	0.92	0.96	-0.84	0.97	0.57	0.94	0.98	0.99	0.99		0.83	0.71	0.99	0.99	0.75	0.47	0.88	0.99	0.83
Net Receivables	0.84	0.85	0.14	0.82	0.82	0.78	0.8	0.7	0.85	-0.82	0.78	0.46	0.72	0.82	0.88	0.84	0.83		0.8	0.84	0.84	0.8	0.46	0.89	0.84	0.55
Common Stock Shares Outstanding	0.74	0.78	0.38	0.76	0.59	0.62	0.63	0.69	0.75	-0.74	0.72	0.52	0.71	0.77	0.78	0.77	0.71	0.8		0.7	0.77	0.76	0.48	0.78	0.77	0.59
Short Term Investments	0.99	0.98	0.38	0.95	0.88	0.56	0.88	0.9	0.98	-0.85	0.95	0.47	0.92	0.96	0.98	0.98	0.99	0.84	0.7		0.98	0.77	0.45	0.89	0.98	0.8
Non Current Liabilities Total	0.99	0.99	0.49	0.99	0.82	0.58	0.84	0.95	0.98	-0.9	0.98	0.54	0.96	0.99	0.99	1.0	0.99	0.84	0.77	0.98		0.81	0.44	0.9	1.0	0.87
Inventory	0.78	0.83	0.52	0.82	0.65	0.68	0.71	0.79	0.82	-0.93	0.79	0.41	0.79	0.8	0.8	0.8	0.75	0.8	0.76	0.77	0.81		0.43	0.95	0.81	0.76
Other Current Assets	0.48	0.4	0.43	0.38	0.6	0.64	0.57	0.31	0.39	-0.36	0.35	0.43	0.33	0.46	0.49	0.43	0.47	0.46	0.48	0.45	0.44	0.43		0.48	0.42	0.26
Other Stockholder Equity	0.9	0.9	0.45	0.9	0.83	0.66	0.88	0.85	0.9	-0.91	0.88	0.56	0.86	0.9	0.9	0.9	0.88	0.89	0.78	0.89	0.9	0.95	0.48		0.9	0.78
Total Liab	0.99	0.99	0.5	0.99	0.81	0.58	0.83	0.96	0.98	-0.9	0.99	0.54	0.97	0.99	0.99	1.0	0.99	0.84	0.77	0.98	1.0	0.81	0.42	0.9		0.88
Property Plant And Equipment Gross	0.84	0.85	0.78	0.92	0.56	0.35	0.63	0.97	0.82	-0.86	0.93	0.49	0.96	0.89	0.82	0.86	0.83	0.55	0.59	0.8	0.87	0.76	0.26	0.78	0.88

Click cells to compare fundamentals

Novocure Account Relationship Matchups

Novocure fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.1B	1.1B	1.2B	1.1B	1.3B	1.4B
Short Long Term Debt Total	444.2M	632.2M	639.1M	596.2M	685.7M	720.0M
Other Current Liab	36.9M	(17.8M)	(18.0M)	59.4M	68.3M	71.7M
Total Current Liabilities	113.6M	142.6M	158.8M	179.1M	206.0M	216.3M
Total Stockholder Equity	476.5M	410.5M	441.2M	362.5M	416.9M	279.7M
Other Liab	11.7M	17.6M	11.2M	7.4M	8.5M	8.8M
Net Tangible Assets	217.8M	476.5M	410.5M	441.2M	507.3M	267.8M
Property Plant And Equipment Net	41.6M	53.9M	69.0M	97.7M	112.4M	118.0M
Net Debt	209.5M	366.4M	468.9M	355.4M	408.7M	429.2M
Retained Earnings	(631.1M)	(685.9M)	(778.5M)	(985.5M)	(887.0M)	(931.3M)
Accounts Payable	53.6M	72.6M	85.2M	94.4M	108.5M	114.0M
Cash	234.7M	208.8M	115.3M	240.8M	276.9M	164.9M
Non Current Assets Total	52.5M	66.0M	80.1M	111.7M	128.5M	134.9M
Non Currrent Assets Other	10.9M	12.1M	11.2M	14.0M	16.1M	16.9M
Other Assets	4.9M	10.9M	12.1M	11.2M	12.8M	13.5M
Long Term Debt	429.9M	562.2M	565.5M	568.8M	654.1M	686.9M
Cash And Short Term Investments	842.6M	937.7M	969.4M	910.6M	1.0B	1.1B
Net Receivables	96.7M	110.6M	112.2M	77.1M	88.7M	60.9M
Common Stock Shares Outstanding	108.9M	103.4M	104.7M	106.4M	122.3M	96.1M
Short Term Investments	607.9M	728.9M	854.1M	669.8M	770.3M	808.8M
Liabilities And Stockholders Equity	1.1B	1.1B	1.2B	1.1B	1.3B	1.4B
Non Current Liabilities Total	461.8M	586.4M	591.7M	604.5M	695.2M	730.0M
Inventory	27.4M	24.4M	29.4M	38.2M	43.9M	23.2M
Other Current Assets	32.7M	807K	6.7M	8.5M	9.8M	6.6M
Other Stockholder Equity	1.1B	1.1B	1.2B	1.4B	1.6B	916.6M
Total Liab	575.5M	729.0M	750.5M	783.6M	901.2M	946.2M
Property Plant And Equipment Gross	41.6M	53.9M	69.0M	152.5M	175.4M	184.2M
Total Current Assets	999.4M	1.1B	1.1B	1.0B	1.2B	607.6M
Accumulated Other Comprehensive Income	(3.8M)	(3.2M)	(2.4M)	(5.5M)	(4.9M)	(4.7M)
Short Term Debt	6.5M	70.0M	73.6M	84.7M	97.4M	53.9M
Property Plant Equipment	34.6M	11.4M	53.9M	32.7M	37.6M	22.9M
Retained Earnings Total Equity	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(700.6M)	(735.6M)
Current Deferred Revenue	17.8M	17.8M	18.0M	16.2M	18.7M	13.4M
Long Term Debt Total	149.5M	429.9M	562.2M	565.5M	650.3M	682.9M
Capital Surpluse	871.4M	1.1B	1.1B	1.2B	1.4B	1.0B
Non Current Liabilities Other	31.9M	166K	148K	18K	20.7K	19.7K
Net Invested Capital	906.4M	972.7M	1.0B	931.3M	1.1B	731.9M
Net Working Capital	885.8M	930.9M	952.8M	855.3M	983.6M	696.2M

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novocure Current Deferred Revenue vs Long Term Debt Analysis

Current Deferred Revenue vs Long Term Debt

Current Deferred Revenue vs Long Term Debt Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Long Term Debt

Novocure fundamental ratios Correlations

Novocure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novocure fundamental ratios Accounts

Additional Tools for Novocure Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Current Liabilities Total	+ 1.0	Long Term Debt
Total Liab	+ 1.0	Long Term Debt
Total Liab	+ 1.0	Non Current Liabilities Total
Non Currrent Assets Other	+ 0.99	Total Assets

Inventory	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Current Liabilities
Other Stockholder Equity	- 0.91	Retained Earnings
Total Liab	- 0.9	Retained Earnings
Non Current Liabilities Total	- 0.9	Retained Earnings
Non Current Assets Total	- 0.9	Retained Earnings